Bispectral Index Monitoring To Guide Sedation In The Critical Care Setting

Overview

A randomized, control trial to compare the total dose of sedatives use in patients over 65 years admitted to the intensive care unit, guiding sedation by monitoring with BIS® versus monitoring with the exclusive use of sedation scales. The study will include all patients over 65 years who enter the intensive care unit of the University Hospital of Bellvitge affected with medical or surgical pathology of non neurological etiology who require sedation for more than 24 hours to maintain adaptation to mechanical ventilation.

Full Title of Study: “Bispectral Index Monitoring To Guide Sedation In Patients With Non-Neurological Pathology Over 65 Years, Admitted To Intensive Care Unit: Randomized Control Trial”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Prevention
    • Masking: None (Open Label)
  • Study Primary Completion Date: June 2018

Detailed Description

Patients admitted to the intensive care unit (ICU) usually require use of hypnotics and sedatives to ensure comfort and proper adaptation to mechanical ventilation. An important requirement for an adequate sedation is frequent and proper assessment of its depth. Inadequate sedation can lead to problems of over-sedation, under-sedation and/or delirium in ICU, especially in elderly patients. The main objective od the study is To compare the total dose of sedative use and the rate of over-sedation in patients over 65 years admitted to the ICU, adjusting sedation by monitoring with BIS® versus monitoring with the exclusive use of sedation scales. METHODS. A randomized, clinical trial including patients over 65 years who were admitted to the ICU affected with medical or surgical pathology of non neurological etiology who required sedation for more than 24 hours to maintain adaptation to mechanical ventilation. Patients were randomized into two groups: the intervention group using BIS monitoring to adjust sedation in order to maintain values between 50-60 and; the control group in which sedation was adjusted with the exclusive use of Richmond Agitation-Sedation Scale (RASS) to maintain RASS -2. The study was approved by the institution's Research Ethics Committee.

Interventions

  • Device: BIS™ Brain Monitoring System
    • The intervention group using BIS monitoring to adjust sedation in order to maintain values between 50-60
  • Other: RASS
    • control group in which sedation was adjusted with the exclusive use of Richmond Agitation-Sedation Scale (RASS) to maintain RASS -2

Arms, Groups and Cohorts

  • Active Comparator: BIS™ Brain Monitoring System
    • BIS monitoring to adjust sedation in order to maintain values between 50-60
  • Placebo Comparator: RASS Monitorization
    • sedation was adjusted with the exclusive useof Richmond Agitation-Sedation Scale (RASS) to maintain RASS -2.

Clinical Trial Outcome Measures

Primary Measures

  • Total Dose of sedation
    • Time Frame: Two years
    • Total dose of sedatives administered in the intervention group compared with the control group.

Participating in This Clinical Trial

Inclusion Criteria

  • Patients over 65 yers – Patients admitted to teintensive care unit of the University Hospital of Bellvitge medical or surgical pathology of neurological etiology – Patiens requiring sedation for more than 24 hours Exclusion Criteria:

  • Patients less than 65 years – Patients admitted to the ICU with Neurological condition. – Postoperative patients admitted and extubation is expected within 24 hours.

Gender Eligibility: All

Minimum Age: 65 Years

Maximum Age: 100 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Hospital Universitari de Bellvitge
  • Provider of Information About this Clinical Study
    • Principal Investigator: Sofia Contreras Medina, Intensivist – Hospital Universitari de Bellvitge
  • Overall Official(s)
    • Luisa Corral, MD, Study Director, Barcelona University

References

Fraser GL, Riker RR. Sedation and analgesia in the critically ill adult. Curr Opin Anaesthesiol. 2007 Apr;20(2):119-23. doi: 10.1097/ACO.0b013e32808255b4.

Carrasco G. Instruments for monitoring intensive care unit sedation. Crit Care. 2000;4(4):217-25. doi: 10.1186/cc697. Epub 2000 Jul 13.

De Deyne C, Struys M, Decruyenaere J, Creupelandt J, Hoste E, Colardyn F. Use of continuous bispectral EEG monitoring to assess depth of sedation in ICU patients. Intensive Care Med. 1998 Dec;24(12):1294-8. doi: 10.1007/s001340050765.

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.